Syncona Limited Director Declaration
March 06 2024 - 12:22PM
RNS Regulatory News
RNS Number : 8912F
Syncona Limited
06 March 2024
Syncona
Limited (the "Company")
Director
Declaration
6 March 2024
In accordance with the requirements
of the Listing Rule 9.6.14R, the Company advises the following
change to directorships in other publicly quoted companies held by
the following member of the Board:
Dr Julie Cherrington was appointed
to Elevation Oncology, Inc. (Nasdaq: ELEV) on 4 March
2024.
Enquiries
Syncona Ltd
Alasdair Moodie
Tel: +44 (0) 20 3981 7940
Citco Fund Services (Guernsey)
Limited
Company Secretary
Tel: +44 (0) 1481 758200
About Syncona:
Syncona's purpose is to invest to
extend and enhance human life. We do this by creating and building
companies to deliver transformational treatments to patients in
areas of high unmet need.
Our strategy is to create, build and
scale companies around exceptional science to create a diversified
portfolio of 20-25 globally leading life science businesses, across
development stage, modality and therapeutic areas, for the benefit
of all our stakeholders. We focus on developing treatments for
patients by working in close partnership with world-class academic
founders and management teams. Our balance sheet underpins our
strategy enabling us to take a long-term view as we look to improve
the lives of patients with no or poor treatment options, build
sustainable life science companies and deliver strong risk-adjusted
returns to shareholders.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
RDNDQLFBZXLLBBB
Syncona (LSE:SYNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Syncona (LSE:SYNC)
Historical Stock Chart
From Apr 2023 to Apr 2024